OLMA · Olema Pharmaceuticals, Inc.
$11.58
-0.18 (-1.53%)
At close · Aug 5
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have incurred net losses since inception, and we expect to continue to incur net losses for the foreseeable future. In addition, we may be unable to continue as a going concern over the long term.”View the 10-Q filed May 12, 2026
Market Cap
$985.28M
Shares
87.35M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Prakash Raman | Class II director | Appointed | 2026-04-29 |
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
31 filings
31 filers
Visit website
Investor relations